{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:21:30Z","timestamp":1788909690491,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100012665","name":"ICES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010661","name":"Southeastern Ontario Academic Medical Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de la recherche en sante du Quebec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Chronic pain is common, and its management is complex in patients with chronic kidney disease (CKD), but limited data are available on opioid prescribing. We examined opioid prescribing for non-cancer and non-end-of-life care in patients with CKD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a population-based retrospective cohort study using administrative databases in Ontario, Canada which included adults with CKD defined by an estimated glomerular filtration rate (eGFR)\u00a0&amp;lt;60\u00a0mL\/min\/1.73\u00a0m2 from 1 November 2012 to 31 December 2018 and estimated the proportion of opioid prescriptions (type, duration, dose, potentially inappropriate prescribing, etc.) within 1 year of cohort entry. Prescriptions had to precede dialysis, kidney transplant or death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 680\u2009445 adults with CKD, and 198\u00a0063 (29.1%) were prescribed opioids. Codeine (14.9%) and hydromorphone (7.2%) were the most common opioids. Among opioid users, 24.3% had repeated or long-term use, 26.1% were prescribed high doses and 56.8% were new users. Opioid users were more likely to be female, had cardiac disease or a mental health diagnosis, and had more healthcare visits. The proportions for potentially inappropriate prescribing indicators varied (e.g. 50.1% with eGFR\u00a0&amp;lt;30\u00a0were prescribed codeine, and 20.6% of opioid users were concurrently prescribed benzodiazepines, while 7.2% with eGFR\u00a0&amp;lt;30 mL\/min\/1.73 m2 were prescribed morphine, and 7.0% were received more than one opioid concurrently). Opioid prescriptions declined with time (2013 cohort: 31.1% versus 2018 cohort: 24.5%; p &amp;lt;0.0001), as did indicators of potentially inappropriate prescribing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Opioid use was common in patients with CKD. While opioid prescriptions and potentially inappropriate prescribing have declined in recent years, interventions to improve pain management without the use of opioids and education on safer prescribing practices are needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfab343","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T20:17:47Z","timestamp":1638908267000},"page":"2408-2417","source":"Crossref","is-referenced-by-count":5,"title":["Opioid prescribing practices in chronic kidney disease: a population-based cohort study"],"prefix":"10.1093","volume":"37","author":[{"given":"Amber O","family":"Molnar","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, McMaster University , Hamilton, ON, Canada"},{"name":"ICES , ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Bota","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Naylor","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M","family":"Nash","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Smith","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita S","family":"Suri","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Center (MUHC), and Division of Nephrology, Department of Medicine , MUHC, Montreal, QC, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M","family":"Sood","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"},{"name":"Division of Nephrology, Department of Medicine, University of Ottawa , Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"},{"name":"Unity Health , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X","family":"Garg","sequence":"additional","affiliation":[{"name":"ICES , ON, Canada"},{"name":"Division of Nephrology, Department of Medicine, Western University , London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"2022112304492939300_bib1","author":"Opioid-and Stimulant-related Harms in Canada (December 2021)"},{"key":"2022112304492939300_bib2","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2468-2667(18)30232-9","article-title":"The opioid death crisis in Canada: crucial lessons for public health","volume":"4","author":"Fischer","year":"2019","journal-title":"Lancet Public Health"},{"key":"2022112304492939300_bib3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"2022112304492939300_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dar.12089","article-title":"Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005\u20132011","volume":"33","author":"Fischer","year":"2014","journal-title":"Drug Alcohol Rev"},{"key":"2022112304492939300_bib5","first-page":"16","article-title":"The rising tide of opioid use and abuse: the role of the anesthesiologist","volume-title":"Perioper Med (Lond)","author":"Koepke","year":"2018"},{"key":"2022112304492939300_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ejp.520","article-title":"Changes in opioid and other analgesic use 1995\u20132010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland","volume":"19","author":"Ruscitto","year":"2015","journal-title":"Eur J Pain"},{"key":"2022112304492939300_bib7","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"key":"2022112304492939300_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0885-3924(01)00396-7","article-title":"Chronic pain prevalence and analgesic prescribing in a general medical population","volume":"23","author":"Clark","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"2022112304492939300_bib9","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/pm\/pnw238","article-title":"Opioid use in chronic pain patients with chronic kidney disease: a systematic review","volume":"18","author":"Nagar","year":"2017","journal-title":"Pain Med"},{"key":"2022112304492939300_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.06520714","article-title":"Chronic pain and analgesic use in CKD: implications for patient safety","volume":"10","author":"Wu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.ajkd.2016.08.039","article-title":"Pain management in CKD: a guide for nephrology providers","volume":"69","author":"Koncicki","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2022112304492939300_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ckj\/sfx080","article-title":"2017 update on pain management in patients with chronic kidney disease","volume":"10","author":"Pham","year":"2017","journal-title":"Clin Kidney J"},{"key":"2022112304492939300_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2215\/CJN.03540318","article-title":"Appropriate use of opioids in patients with kidney diseases","volume":"13","author":"White","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/sdi.12196","article-title":"Pain in chronic kidney disease: a scoping review","volume":"27","author":"Davison","year":"2014","journal-title":"Semin Dial"},{"key":"2022112304492939300_bib15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.amjmed.2019.06.014","article-title":"Opioid management in older adults with chronic kidney disease: a review","volume":"132","author":"Owsiany","year":"2019","journal-title":"Am J Med"},{"key":"2022112304492939300_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2215\/CJN.05180418","article-title":"Clinical pharmacology considerations in pain management in patients with advanced kidney failure","volume":"14","author":"Davison","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib17","doi-asserted-by":"crossref","first-page":"280.e281","DOI":"10.1016\/j.amjmed.2006.02.015","article-title":"NSAID use and progression of chronic kidney disease","volume":"120","author":"Gooch","year":"2007","journal-title":"Am J Med"},{"key":"2022112304492939300_bib18","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2215\/CJN.04970512","article-title":"Critical and honest conversations: the evidence behind the \u201cChoosing Wisely\u201d campaign recommendations by the American Society of Nephrology","volume":"7","author":"Williams","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/JPR.S244173","article-title":"The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain?","volume":"13","author":"Yang","year":"2020","journal-title":"J Pain Res"},{"key":"2022112304492939300_bib20","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2215\/CJN.12311216","article-title":"Patterns of NSAIDs use and their association with other analgesic use in CKD","volume":"12","author":"Zhan","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib21","doi-asserted-by":"crossref","first-page":"e2016839","DOI":"10.1001\/jamanetworkopen.2020.16839","article-title":"Assessment of prescription analgesic use in older adults with and without chronic kidney disease and outcomes","volume":"3","author":"Han","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022112304492939300_bib22","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2215\/CJN.08530718","article-title":"Prevalence of opioid, gabapentinoid, and NSAID use in patients with CKD","volume":"13","author":"Novick","year":"2018","journal-title":"Clin J Soc Nephrol"},{"key":"2022112304492939300_bib23","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1681\/ASN.2017091041","article-title":"Prescription opioids for pain management in patients on dialysis","volume":"28","author":"Han","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492939300_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2215\/CJN.09910917","article-title":"Opioid analgesics and adverse outcomes among hemodialysis patients","volume":"13","author":"Ishida","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib25","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1681\/ASN.2018010096","article-title":"Gabapentin and pregabalin use and association with adverse outcomes among hemodialysis patients","volume":"29","author":"Ishida","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492939300_bib26","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1681\/ASN.2017010098","article-title":"Opioid prescription, morbidity, and mortality in united states dialysis patients","volume":"28","author":"Kimmel","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022112304492939300_bib27","first-page":"1","article-title":"Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis","volume":"7","author":"Davison","year":"2020","journal-title":"Can J Kid Health Dis"},{"key":"2022112304492939300_bib28","doi-asserted-by":"crossref","first-page":"e0125620","DOI":"10.1371\/journal.pone.0125620","article-title":"The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: methods for arriving at consensus and developing reporting guidelines","volume":"10","author":"Nicholls","year":"2015","journal-title":"PLoS One"},{"key":"2022112304492939300_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2215\/CJN.06680810","article-title":"A validation study of the Canadian Organ Replacement Register","volume":"6","author":"Moist","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022112304492939300_bib30","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"2022112304492939300_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022112304492939300_bib32","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"key":"2022112304492939300_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"key":"2022112304492939300_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgrad Med"},{"key":"2022112304492939300_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/ADM.0000000000000354","article-title":"Concurrent use of opioids and benzodiazepines: evaluation of prescription drug monitoring by a United States Laboratory","volume":"11","author":"McClure","year":"2017","journal-title":"Addict Med"},{"key":"2022112304492939300_bib36","doi-asserted-by":"crossref","first-page":"e2028557","DOI":"10.1001\/jamanetworkopen.2020.28557","article-title":"Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999\u20132015","volume":"3","author":"Xu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022112304492939300_bib37","volume-title":"ODPRN Suggested Calculation of Opioid Milligrams of Morphine Equivalents","author":"Ontario Drug Policy Research Network","year":"2020"},{"key":"2022112304492939300_bib38","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"2022112304492939300_bib39","volume-title":"Opioid Prescribing in Canada: How Are Practices Changing","author":"Canadian Institute for Health Information","year":"2019"},{"key":"2022112304492939300_bib40","volume-title":"Pan-Canadian Trends in the Prescribing of Opioids and Benzodiazepines, 2012 to 2017","author":"Canadian Institute for Health Information","year":"2018"},{"key":"2022112304492939300_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","author":"2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2022112304492939300_bib42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3389\/fphar.2019.00932","article-title":"Neuropsychiatric disorders in chronic kidney disease","volume":"10","author":"Sim\u00f5es","year":"2019","journal-title":"Front Pharmacol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfab343\/42549000\/gfab343.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/12\/2408\/47203134\/gfab343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/12\/2408\/47203134\/gfab343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:49:53Z","timestamp":1669178993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/12\/2408\/6458366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,9]]},"published-print":{"date-parts":[[2022,11,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfab343","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2021,12,9]]}}}